Furthermore, some oncogenic genes like EGFR, CDK6, YAP1, and MMP7 were amplified in the TP53INP2-low patients while some tumor suppressor genes including CDKN2A, KLF6, and PTEN were deleted. This evidence concerns the gene TP53INP2 and neoplasm.